Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
0.325
+0.004 (1.25%)
At close: Dec 20, 2024, 4:00 PM
0.329
+0.004 (1.35%)
After-hours: Dec 20, 2024, 6:21 PM EST
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $3.23 million as of December 20, 2024. Its market cap has decreased by -7.21% in one year.
Market Cap
3.23M
Enterprise Value
120.42K
1-Year Change
-7.21%
Ranking
Category
Stock Price
$0.33
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $792.87M to $3.23M, a decrease of -99.59%. That is a compound annual growth rate of -74.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 3.23M | 7.10% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -96.32% |
| Dec 31, 2020 | 792.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sharps Technology | 3.40M |
| Pasithea Therapeutics | 3.38M |
| HeartSciences | 3.35M |
| Check-Cap | 3.34M |
| Quoin Pharmaceuticals | 3.27M |
| 60 Degrees Pharmaceuticals | 3.24M |
| Alaunos Therapeutics | 3.23M |
| Aditxt | 3.22M |